ログイン
言語:

WEKO3

  • トップ
  • ランキング
To

Field does not validate

To

Field does not validate



インデックスリンク

インデックスツリー

  • RootNode

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学術雑誌論文
  2. 各雑誌掲載論文

Simple LC-MS/MS method using core-shell ODS microparticles for the simultaneous quantitation of edoxaban and its major metabolites in human plasma

http://hdl.handle.net/10271/00004154
http://hdl.handle.net/10271/00004154
cd0c9a66-c376-4402-b9a8-288db3831aac
名前 / ファイル ライセンス アクション
J J Chromatogr B-1146-122121.pdf (1.1 MB)
license.icon
Item type 学術雑誌論文 / Journal Article(1)
公開日 2022-06-10
タイトル
タイトル Simple LC-MS/MS method using core-shell ODS microparticles for the simultaneous quantitation of edoxaban and its major metabolites in human plasma
言語 en
言語
言語 eng
キーワード
主題 Edoxaban
キーワード
主題 metabolites
キーワード
主題 LC-MS/MS
キーワード
主題 human plasma
キーワード
主題 pharmacokinetics
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 Ariizumi, Saki

× Ariizumi, Saki

Ariizumi, Saki

Search repository
Naito, Takafumi

× Naito, Takafumi

Naito, Takafumi

Search repository
Hoshikawa, Kohei

× Hoshikawa, Kohei

Hoshikawa, Kohei

Search repository
Akutsu, Shunta

× Akutsu, Shunta

Akutsu, Shunta

Search repository
Saotome, Masao

× Saotome, Masao

Saotome, Masao

Search repository
Maekawa, Yuichiro

× Maekawa, Yuichiro

Maekawa, Yuichiro

Search repository
Kawakami, Junichi

× Kawakami, Junichi

Kawakami, Junichi

Search repository
書誌情報 Journal of Chromatography B

巻 1146, p. 122121, 発行日 2020-07
出版者
出版者 Elsevier
権利
権利情報 Copyright?2020. This manuscript version is made available under the CC-BY-NC-ND 4.0 license?http://creativecommons.org/licenses/by-nc-nd/4.0/
権利
権利情報 This is the accepted manuscript version. The formal published version is available at https://doi.org/10.1016/j.jchromb.2020.122121.
抄録
内容記述タイプ Abstract
内容記述 Edoxaban is mainly enzymatically converted to a 4-carboxylic acid form (4CA-EDX) and an N-desmethyl form (ND-EDX) in humans. This study aimed to establish a simple liquid chromatography-tandem mass spectrometry method using core-shell octadecyl silica (ODS) microparticles for the simultaneous quantitation of edoxaban and its two major metabolites in human plasma. Analytes extracted from plasma specimens by a one-step deproteinization were separated using a 2.6-μm core-shell ODS microparticulate column and linear acetonitrile-ammonium acetate gradient elution at a flow rate of 0.25mL/min with a run time of 7 minutes. The mass spectrometer was operated in the positive ion multiple reaction monitoring mode. Plasma samples collected from 20 patients with atrial fibrillation were analyzed by the present method. The chromatograms of drug-free human plasma had no interfering peaks. The calibration curves of edoxaban, 4CA-EDX, and ND-EDX were linear over the concentration ranges of 1.25?160, 0.47?60, and 0.12?15ng/mL, respectively. Their pretreatment recoveries and matrix factors were 88.7?109.0% and 87.0?101.6%, respectively. The intra- and inter-day accuracy and imprecision values were 85.9?112.8% and within 13.3%, respectively. The plasma concentrations of edoxaban, 4CA-EDX, and ND-EDX in the patients had ranges of 17.8?102, 1.67?25.7, and 0.685?5.34ng/mL, respectively. All the analytes were measurable within their calibration curves. In conclusion, this validated method for the simultaneous determination of edoxaban and its major metabolites was successfully applied to plasma specimens obtained from patients with atrial fibrillation.
ISSN
収録物識別子タイプ ISSN
収録物識別子 1570-0232
EISSN
収録物識別子タイプ ISSN
収録物識別子 1873-376X
PubMed番号
関連タイプ isVersionOf
識別子タイプ PMID
関連識別子 32361632
出版社DOI
関連タイプ isVersionOf
識別子タイプ DOI
関連識別子 10.1016/j.jchromb.2020.122121
著者版フラグ
出版タイプ AM
出版タイプResource http://purl.org/coar/version/c_ab4af688f83e57aa
戻る
0
views
See details
Views

Versions

Ver.1 2023-06-20 16:19:42.142076
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3